Comparison of Percutaneous Coronary Intervention With Bare-Metal and Drug-Eluting Stents for Cardiac Allograft Vasculopathy

JACC: Cardiovascular Interventions

Volumn 1, Issue 6, 2008, Pages 710-715

  Lee, Michael S ^a   Kobashigawa, Jon ^a   Tobis, Jonathan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cardiac transplantation; drug eluting stent; percutaneous coronary intervention

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NITRATE; PACLITAXEL; PREDNISONE; RAPAMYCIN; SULFONYLUREA DERIVATIVE; TACROLIMUS;

ANGIOGRAPHY; ARTICLE; BARE METAL STENT; CARDIAC ALLOGRAFT VASCULOPATHY; COMPARATIVE STUDY; CORONARY STENT; DIABETES MELLITUS; DRUG ELUTING STENT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEART TRANSPLANTATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RESTENOSIS; RETROSPECTIVE STUDY; REVASCULARIZATION; THROMBOSIS; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; DRUG-ELUTING STENTS; FEMALE; GRAFT OCCLUSION, VASCULAR; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMANS; LOS ANGELES; MALE; METALS; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STENTS; THROMBOSIS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 57549100589     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2008.10.001     Document Type: Article

References (40)

1. Heublein B., Pethig K., Maab C., Wahlers T., and Haverich A. Coronary artery stenting in cardiac allograft vascular disease. Am Heart J 134 (1997) 930-938
2. Taylor D.O., Edwards L.B., Boucek M.M., et al. The registry of the International Society for Heart and Lung Transplantation: twenty-first official adult heart transplant report-2004. J Heart Lung Transplant 23 (2004) 796-803
3. Miller L.W., Schlant R.C., Kobashigawa J., Kubo S., and Renlund D.G. Twenty-fourth Bethesda conference: cardiac transplantation. Task Force 5: complications. J Am Coll Cardiol 22 (1993) 41-54
4. Kobashigawa J.A., Katznelson S., Laks H., et al. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med 333 (1995) 621-627
5. Wenke K., Meiser B., Thiery J., et al. Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial. Circulation 96 (1997) 1398-1402
6. Avery R.K. Cardiac-allograft vasculopathy. N Engl J Med 349 (2003) 829-830
7. Halle III A.A., DiSciascio G., Massin E.K., et al. Coronary angioplasty, atherectomy and bypass surgery in cardiac transplant recipients. J Am Coll Cardiol 26 (1995) 120-128
8. Copeland J.G., Butman S.M., and Sethi G. Successful coronary artery bypass grafting for high-risk left main coronary artery atherosclerosis after cardiac transplantation. Ann Thorac Surg 49 (1990) 106-110
9. Frazier O.H., Vega J.D., Duncan J.M., et al. Coronary artery bypass two years after orthotopic heart transplantation: a case report. J Heart Lung Transplant 10 (1991) 1036-1040
10. Miller L.W., Donohue T.J., and Wolford T.A. The surgical management of allograft coronary artery disease: a paradigm shift. Semin Thorac Cardiovasc Surg 8 (1996) 133-138
11. Musci M., Loebe M., Wellnhofer E., et al. Coronary angioplasty, bypass surgery, and retransplantation in cardiac transplantation patients with graft coronary disease. Thorac Cardiovasc Surg 46 (1998) 268-274
12. Dunning J.J., Kendall S.W., Mullins P.A., et al. Coronary artery bypass grafting nine years after cardiac transplantation. Ann Thorac Surg 54 (1992) 571-572
13. Sandhu J.S., Uretsky B.F., Reddy P.S., et al. Potential limitations of percutaneous transluminal coronary angioplasty in heart transplant recipients. Am J Cardiol 69 (1992) 1234-1237
14. Christensen B.V., Meyer S.M., Iacarella C.L., Kubo S.H., and Wilson R.F. Coronary angioplasty in heart transplant recipients: a quantitative angiographic long-term follow-up study. J Heart Lung Transplant 13 (1994) 212-220
15. Johnson T.H., Das G.S., McGinn A.L., Christensen B.V., Meyer S.M., and Wilson R.F. Physiologic assessment of the coronary collateral circulation in transplanted human hearts. J Heart Lung Transplant 13 (1994) 840-846
16. von Scheidt W., Uberfuhr P., Reichart B., and Steinbeck G. The role of PTCA in the management of focal critical lesions in transplant coronary artery disease. Transplant Proc 27 (1995) 1936-1938
17. Redonnet M., Tron C., Koning R., et al. Coronary angioplasty and stenting in cardiac allograft vasculopathy following heart transplantation. Transplant Proc 32 (2000) 463-465
18. Tanaka K., Li H., Curran P.J., et al. Usefulness and safety of percutaneous coronary intervention for cardiac transplant vasculopathy. Am J Cardiol 97 (2006) 1192-1197
19. Benza R.J., Zoghbi G.J., Tallaj J., et al. Palliation of allograft vasculopathy with transluminal angioplasty: a decade of experience. J Am Coll Cardiol 43 (2004) 1973-1981
20. Jain S.B., Ramee S.R., White T.J., et al. Coronary stenting in cardiac allograft vasculopathy. J Am Coll Cardiol 32 (1998) 1636-1640
21. Doshi A.A., Rogers J., Kern M.J., and Hauptman P.J. Effectiveness of percutaneous coronary intervention in cardiac allograft vasculopathy. Am J Cardiol 93 (2004) 90-92
22. Simpson L., Lee E.K., Hott B.J., Vega D.J., and Book W.M. Long-term results of angioplasty vs stenting in cardiac transplant recipients with allograft vasculopathy. J Heart Lung Transplant 24 (2005) 1211-1217
23. Wong P., Piamsomboon C., Mathur A., et al. Efficacy of coronary stenting in the management of cardiac allograft vasculopathy. Am J Cardiol 82 (1998) 239-241
24. Bader F.M., Kfoury A.G., Gilbert E.M., et al. Percutaneous coronary interventions with stents in cardiac transplant recipients. Percutaneous coronary interventions with stents in cardiac transplant recipients. J Heart Lung Transplant 25 (2006) 298-301
25. Lee M.S., Chun K.J., and Tobis J. Drug-eluting stenting of unprotected left main coronary artery stenosis in patients with orthotopic heart transplantation: initial clinical experience. Catheter Cardiovasc Interv 71 (2008) 306-311
26. Moses J.W., Leon M.B., Popma J.J., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
27. Stone G.W., Ellis S.G., Cox D.A., et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
28. Morice M.C., Serruys P.W., Sousa J.E., et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
29. Ryan T.J., Bauman W.B., Kennedy J.W., et al. Guidelines for percutaneous transluminal coronary angioplasty: a report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 22 (1993) 2033-2054
30. Keogh A.M., Valantine H.A., Hunt S.A., et al. Impact of proximal or midvessel discrete coronary artery stenoses on survival after heart transplantation. J Heart Lung Transplant 11 (1992) 892-901
31. Gao S.Z., Hunt S.A., Schroeder J.S., Alderman E., Hill I.R., and Stinson E.B. Does rapidity of development of transplant coronary artery disease portend a worse prognosis?. J Heart Lung Transplant 13 (1994) 1119-1124
32. Gao S.Z., Schroeder J.S., Hunt S., and Stinson E.B. Retransplantation for severe accelerated coronary artery disease in heart transplant recipients. Am J Cardiol 62 (1988) 876-881
33. Ensley R.D., Hunt S., Taylor D.O., et al. Predictors of survival after repeat heart transplantation. J Heart Lung Transplant 11 (1992) S142-S148
34. Parry A., Roberts M., Parameshwar J., et al. The management of post-cardiac transplantation coronary artery disease. Eur J Cardiothorac Surg 10 (1996) 528-532
35. Zakliczynski M., Lekston A., Osuch M., et al. Comparison of long-term results of drug-eluting stent and bare metal stent implantation in heart transplant recipients with coronary artery disease. Transplant Proc 39 (2007) 2859-2861
36. Wessely R., Pache J., and Schömig A. Recurrence of in-stent restenosis in cardiac allograft vasculopathy following implantation of a sirolimus-eluting stent. Transplant Int 18 (2005) 1113-1115
37. Matos G., Steen L., and Leya F. Treatment of unprotected left main coronary artery stenosis with a drug eluting stent in a heart transplant patient with allograft vasculopathy. Heart 91 (2005) e11
38. Yoon EJ Haeussiein E., and Brent B. Long-term follow up after coronary sirolimus drug-eluting stent implantation for cardiac transplant arteriopathy. J Invasive Cardiol 18 (2006) 184-185
39. Pfisterer M., Brunner-La Rocca H.P., Buser P.T., et al. Late clinical events after clopidogrel discontinuation might limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare metal stents. J Am Coll Cardiol 48 (2006) 2584-2591
40. Iakovou I., Schmidt T., Bonizzoni E., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130